scorecardresearchSun Pharmaceutical Industries Share Price Live NSE, BSE, Today - Sun Pharmaceutical Industries Stock Price
Mintgenie
Asian Paints3,235.15-5.30 (-0.16%)
Axis Bank926.006.50 (0.71%)
Bajaj Finance7,023.00-17.80 (-0.25%)
Bajaj Finserve1,456.556.15 (0.42%)
Bharti Airtel836.208.15 (0.98%)
HCL Technologies1,136.90-4.30 (-0.38%)
HDFC Bank1,606.152.05 (0.13%)
Hindustan Unilever2,716.3518.60 (0.69%)
Housing Development Finance Corporation2,641.35-4.45 (-0.17%)
ICICI Bank937.051.00 (0.11%)
ITC443.203.40 (0.77%)
Indusind Bank1,288.10-3.15 (-0.24%)
Infosys1,298.65-20.80 (-1.58%)
Kotak Mahindra Bank1,939.7511.25 (0.58%)
Larsen & Toubro2,235.2526.20 (1.19%)
Mahindra & Mahindra1,341.4022.55 (1.71%)
Maruti Suzuki India9,488.80161.00 (1.73%)
NTPC174.20-0.10 (-0.06%)
Nestle India22,020.00161.10 (0.74%)
Power Grid Corporation Of India234.601.70 (0.73%)
Reliance Industries2,454.95-7.10 (-0.29%)
State Bank Of India587.204.60 (0.79%)
Sun Pharmaceutical Industries999.3511.85 (1.20%)
Tata Consultancy Services3,308.00-15.30 (-0.46%)
Tata Motors535.750.50 (0.09%)
Tata Steel108.002.05 (1.93%)
Tech Mahindra1,122.301.35 (0.12%)
Titan Company2,859.6032.90 (1.16%)
Ultratech Cement7,849.406.70 (0.09%)
Wipro404.80-2.45 (-0.60%)

Sun Pharmaceutical Industries

BSE: 524715 | NSE: SUNPHARMA | ISIN: INE044A01036 | SECTOR: Biotechnology & Drugs

₹999.35 11.85 (1.2%)

02 Jun 2023, 10:19 (IST)

  • Open

    987.95

  • High

    1,003.85

  • Low

    981.35

  • Prev Close

    987.50

  • P/E

    -

  • Median P/E

    -

  • P/B

    -

  • Median P/B

    -

  • Market Cap

    2,397.78B

  • Volume

    41.74K

  • Vol. (20 day Avg.)

    0

  • PEG

    -

  • Div.Yield

    -

  • Bid

    -

  • Ask

    -
View all metrics

Promoter Pledge Holding - 0.97%

Promoter NameNo of SharesPercentage
Aditya Medisales Limited10,0000.00%
Raksha S.Valia2,32,20,0000.96%
Kumud Shantilal Shanghvi1,00,0000.00%

Company Description

  • Biotechnology & Drugs

  • BSE

    524715

  • NSE

    SUNPHARMA

  • ISIN

    INE044A01036

Sun Pharmaceutical Industries Limited is a specialty generic pharmaceutical company. The Company is engaged in the business of manufacturing, developing and marketing a range of generic formulations. It produces a portfolio of generic and specialty medicines targeting a spectrum of chronic and acute treatments. The Company’s product portfolio includes generics, branded generics, specialty, over the counter (OTC)/consumer healthcare products, anti-retrovirals (ARVs), active pharmaceutical ingredients (APIs) and intermediates. Its OTC brands includes Faringosept , Revital, and Volini. The Company offers its products in variety of dosage forms, such as tablets, capsules, sprays, injectables, inhalers, ointments, creams and liquids. Its portfolio of specialty products, branded generics are available across 100 countries. The Company operates manufacturing sites across 6 continents.

Company Officers

  • C. S. Muralidharan

    Chief Financial Officer

  • Uday Baldota

    Chief Executive Officer - Taro Pharmaceutical Industries Limited

  • Abhay Gandhi

    Chief Executive Officer - North America

  • Kirti Ganorkar

    Chief Executive Officer - India Business

  • Aalok Shanghvi

    Executive Vice President, Head - Emerging Markets, Head - Global Generics, Research and Development, Business Development, WholeTime Director.

  • Jila Breeze

    Executive Vice President, Global Head - Quality

  • Davinder Singh

    Executive Vice President - Sun Global Operations

  • Anil Rao

    Senior Vice President, Chief Information Officer

  • Sapna Purohit

    Senior Vice President, Head of Human Resources

  • Azadar Khan

    Senior Vice President - Corporate Relations and Corporate Social Responsibility, India Regulatory Affairs